𝔖 Bobbio Scriptorium

✦ LIBER ✦

Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility

✍ Scribed by Vishvanath C. Karande; Alan Korn; Randy Morris; Ramaa Rao; Martin Balin; John Rinehart; Karen Dohn; Norbert Gleicher

Book ID: 119423157
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 100 KB
Volume: 71
Category: Article
ISSN: 1556-5653
DOI: 10.1016/s0015-0282(98)00490-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CEFEPIME VERSUS CETAZIDIME+AMIKACIN AS E

CEFEPIME VERSUS CETAZIDIME+AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER: A Prospective Randomized Trial of the Treatment Efficacy and Cost

✍ Çorapçioglu, Funda; Sarper, Nazan 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 132 KB

First results of a randomized phase III

First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) — EORTC 10951 in collaboration with the exemestane working group and NCIC Clinical Trials Group

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Autologous bone marrow transplantation a

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

✍ Dimitri A. Breems; Marc A. Boogaerts; Adriaan W. Dekker; Wim L. J. Van Putten; P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB